This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: Bruce F Michael: Innovator in Anthelmintic Treatments
Introduction
Bruce F Michael is a notable inventor based in Whitehouse Station, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of helminthiasis. His innovative approach has led to the development of a unique method that utilizes nodulisporic acid and its analogs.
Latest Patents
Bruce F Michael holds a patent for the "Anthelmintic use of nodulisporic acid and analogs thereof." This invention provides a method for treating helminthiasis by administering an effective amount of nodulisporic acid or an analog to an infected host. This patent highlights his commitment to advancing medical treatments and improving health outcomes.
Career Highlights
Bruce F Michael is associated with Merck & Co., Inc., a leading global healthcare company. His work at Merck has allowed him to collaborate with other talented professionals in the field. His dedication to research and innovation has positioned him as a key figure in the development of new therapeutic methods.
Collaborations
Throughout his career, Bruce has worked alongside esteemed colleagues such as Wesley L Shoop and Dan A Ostlind. These collaborations have fostered an environment of innovation and have contributed to the success of his projects.
Conclusion
In summary, Bruce F Michael is a distinguished inventor whose work in the field of anthelmintic treatments has made a significant impact. His patent for the use of nodulisporic acid exemplifies his innovative spirit and dedication to improving health solutions.